Drug Combinations Targeting FAK and MEK Overcomes Tumor Heterogeneity in Glioblastoma
Furqan M. et al, (2025), Pharmaceutics, 17, 549 - 549
A High-Throughput Drug Repurposing Strategy to Treat TBX2 and/or TBX3 Dependent Cancers.
Bleloch JS. et al, (2024), Cancer medicine, 13
Reduction of Z alpha-1 antitrypsin polymers in human iPSC-hepatocytes and mice by LRRK2 inhibitors.
Kent D. et al, (2024), Hepatology (Baltimore, Md.)
Improving the representativeness of UK’s national COVID-19 Infection Survey through spatio-temporal regression and post-stratification
Pouwels KB. et al, (2024), Nature Communications, 15
Targeting NKG2D ligands in glioblastoma with a bispecific T-cell engager is augmented with conventional therapy and enhances oncolytic virotherapy of glioma stem-like cells
Baugh R. et al, (2024), Journal for ImmunoTherapy of Cancer, 12, e008460 - e008460
Optimized protocol for CRISPR knockout of human iPSC-derived macrophages
Navarro-Guerrero E. et al, (2024), STAR Protocols, 5, 102903 - 102903
Persistence of SARS-CoV-2 antibodies over 18 months following infection: UK Biobank COVID-19 Serology Study
Bešević J. et al, (2024), Journal of Epidemiology and Community Health, 78, 105 - 108
Author Correction: C16orf72/HAPSTR1/TAPR1 functions with BRCA1/Senataxin to modulate replication-associated R-loops and confer resistance to PARP disruption.
Sharma AB. et al, (2023), Nature communications, 14
Selective ROCK Inhibitor Enhances Blood Flow Recovery after Hindlimb Ischemia
Fayed HS. et al, (2023), International Journal of Molecular Sciences, 24, 14410 - 14410
Chemogenomic library design strategies for precision oncology, applied to phenotypic profiling of glioblastoma patient cells
Athanasiadis P. et al, (2023), iScience, 26
COVID-19 vaccination, risk-compensatory behaviours, and contacts in the UK
Buckell J. et al, (2023), Scientific Reports, 13
Protection against SARS-CoV-2 Omicron BA.4/5 variant following booster vaccination or breakthrough infection in the UK
Wei J. et al, (2023), Nature Communications, 14
Continuous population-level monitoring of SARS-CoV-2 seroprevalence in a large European metropolitan region
Emmenegger M. et al, (2023), iScience, 26, 105928 - 105928
Small-molecule Polθ inhibitors provide safe and effective tumor radiosensitization in preclinical models
Rodriguez-Berriguete G. et al, (2023), Clinical Cancer Research
Glioblastoma and the search for non-hypothesis driven combination therapeutics in academia
Johanssen T. et al, (2023), Frontiers in Oncology, 12
Longitudinal characterization of TK6 cells sequentially adapted to animal product-free, chemically defined culture medium: considerations for genotoxicity studies.
Perez-Diaz N. et al, (2023), Frontiers in toxicology, 5
A genome-wide CRISPR screen identifies CALCOCO2 as a regulator of beta cell function influencing type 2 diabetes risk.
Rottner AK. et al, (2022), Nature genetics
Omicron-associated changes in SARS-CoV-2 symptoms in the United Kingdom
Vihta1 KD. et al, (2022), Clinical Infectious Diseases
SARS-CoV-2 antibody trajectories after a single COVID-19 vaccination with and without prior infection
Wei J. et al, (2022), Nature Communications, 13
Automated 96-well format high throughput colony formation assay for siRNA library screen
Hatch SB. et al, (2022), STAR Protocols, 3, 101355 - 101355